-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vq8D6OLlIB/l2L2tPTGSc3LtAClYkwmr0IUNJFiWayiuoQMm+JxouefZis8IawhT pWKpxgPXhOCl5fsRhHAJjg== 0000904454-04-000248.txt : 20040414 0000904454-04-000248.hdr.sgml : 20040414 20040414115343 ACCESSION NUMBER: 0000904454-04-000248 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040414 FILED AS OF DATE: 20040414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50677 FILM NUMBER: 04732150 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNICON CORP CENTRAL INDEX KEY: 0001083132 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] BUSINESS ADDRESS: STREET 1: 3401 MASONS MILL RD STREET 2: SUITE 100 CITY: HUNTINGTON VALLEY STATE: PA ZIP: 19006 BUSINESS PHONE: 215 830 0777 X121 3 1 edgar.xml PRIMARY DOCUMENT X0201 3 2004-04-14 0 0001083132 IMMUNICON CORP IMMC 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 0 1 0 Common Stock 5000 I By Johnson & Johnson Development Corporation Series E Preferred Stock Common Stock 703236 I By Johnson & Johnson Development Corporation Series F Preferred Stock Common Stock 1050000 I By Johnson & Johnson Development Corporation Common Stock Purchase Warrant 2.40 2002-01-18 2004-07-13 Common Stock 2667 I By Johnson & Johnson Development Corporation Common Stock Purchase Warrant 2.40 2003-01-17 2004-07-13 Common Stock 5334 I By Johnson & Johnson Development Corporation Common Stock Purchase Warrant 2.40 2004-01-16 2004-07-13 Common Stock 5334 I By Johnson & Johnson Development Corporation The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person. All of the outstanding shares of the Issuer's Series E Convertible Preferred Stock will convert automatically on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. All of the outstanding shares of the Issuer's Series F Convertible Preferred Stock will convert automatically on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. The warrant vests in equal installments yearly, over two years, and expires ten years from the date of grant. Upon the closing of the Issuer's initial public offering, the warrant will become fully exercisable. Michael H. Ullman, Secretary 2004-04-14 -----END PRIVACY-ENHANCED MESSAGE-----